Clinical Care M&A Momentum Continues
M&A remains strong in 2018 in the Clinical Care markets driven in part by the reality that the costs of care are increasingly shifting to a value-based model. Providers fully recognize, as we shift from a volume-based reimbursement environment to something more value-based, that having different pieces of the care continuum is more and more important. Payers and providers are going to be looking for more vertical acquisition-type opportunities. Building out a care continuum will lead to more effective outcomes for patients, and that’s going to benefit shareholders.
When contemplating a merger or acquisition of a patient-facing practice, a buyer or investor must examine the strength and reach of the reputation of the practice among many other factors. SC&H’s new report, “Capital Insights: Clinical Care M&A Outlook: The Prognosis For 2018 Deal Flow,” delves into a variety of insights, from:
- How patient-facing clinical practices are being affected
- Who are the buyers and what is driving demand?
- What buyers and investors value in patient-facing clinical practices
- What patient-facing clinical practices should know
About Capital Insights
SC&H Capital has launched Capital Insights – a content series to highlight our in-depth knowledge of prominent industries in the market place through the perspectives of innovation and differentiation. Our goal is to share actionable insights that businesses can use to assess their competitive advantage and potential strategic options through this information.